El impacto económico de la hepatitis C en Australia

Este informe llega a la conclusión de que invertir en nuevos tratamientos contra la hepatitis C curará a más personas de una enfermedad crónica y costosa, y proporcionará notables beneficios económicos a la sociedad en el largo plazo.Más información, en inglés, está disponible abajo.

Suscríbase a las Alertas mensuales del IDPC para recibir información sobre cuestiones relacionadas con políticas sobre drogas.

Hepatitis Australia's mission is to ensure the needs of Australians affected by, or at risk of, viral hepatitis are met. The hepatitis C virus attacks the liver and can lead to a long-term, potentially life-threatening liver disease. The very low level of hepatitis C treatment in Australia contributes to a growing burden of disease and rising health care costs.

This report comes at a critical time. The outlook is bright for many people living with hepatitis C. New hepatitis C medications with significantly improved cure rates are becoming a reality after many years of minimal change in the treatment landscape.

The report concludes that investment in new hepatitis C treatment will cure more people of a chronic and costly condition and provide substantial economic benefits for society in the long term.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.